INTRODUCTION
============

An increased interest in conjugated linoleic acid (CLA) in the dairy industry is attributed to its positive role in cancer prevention, decreased risk of atherosclerosis, and improved immune response ([@b2-ajas-29-3-365]; [@b10-ajas-29-3-365]; [@b7-ajas-29-3-365]). The predominant natural CLA isomer is *cis*-9, *trans*-11 CLA, which account for 80% to 90% of the total CLA in dairy products ([@b21-ajas-29-3-365]; [@b3-ajas-29-3-365]). The activity of a variety of ruminal microbes plays a key role in the conversion of dietary polyunsaturated fatty acids (PUFAs) to saturated fatty acids (SFAs) through the biohydrogenation pathways in the rumen. Linoleic acid (LA), the most common natural source of CLA, is converted to CLA and/or rapidly disappears in the rumen via the activity of ruminal bacteria and enzymes through the metabolic processes ([@b1-ajas-29-3-365]; [@b25-ajas-29-3-365]). Alternatively, CLA occurs as an intermediate during the biohydrogenation of LA in the rumen by *Butyrivibrio fibrisolvens* (*B. fibrisolvens*) ([@b14-ajas-29-3-365]). The high degree of accumulation of natural CLA in dairy products is attributed to the increase in the availability of lipids by manipulation of feeds consisting mainly of grains and seed oils for ruminal biohydrogenation ([@b12-ajas-29-3-365]). According to the study by [@b6-ajas-29-3-365], feeding lipid sources, roasted cracked soybeans, soybean oil, and linseed oil, increased the CLA content of cattle milk when oils were accessible to the rumen microorganisms for biohydrogenation. [@b27-ajas-29-3-365] reported that the amount of CLA was increased by the addition of fish oil, without causing an adverse effect on ruminal fermentation. In addition, [@b24-ajas-29-3-365] showed that the effect of tanniniferous *Terminalia chebula* extract on the rumen biohydrogenation contributed to increased CLA content in the muscle of goat kids. On the other hand, *B. fibrisolvens*, which is known to be a major CLA-producing ruminal bacterium, exhibits high biohydrogenation activity, which consumes CLA. Therefore, the protection of CLA from the biohydrogenation attracted great attention. However, limited studies have shown on the stability of nano-encapsulated CLA against the ruminal biohydrogenation from by ruminal microbes.

This study aimed to evaluate the *in vitro* effect of chemically synthesized nano-encapsulated CLA on the stability of CLA and the ruminal fermentation characteristics.

MATERIALS AND METHODS
=====================

Ruminal inoculum and *in vitro* incubation
------------------------------------------

A fistulated Holstein cow was used as a donor of rumen fluid. The commercial concentrate (Saesam, Daehan feed Co., LTD., Incheon, Korea) was fed at 3 kg a day. Rice straw, water and mineral-vitamin block were allowed *ad libitum*. The rumen samples were collected before feeding. Rumen fluid was strained through four layers of cheesecloth before mixing with buffer and was maintained at 39°C. The 30 mL of rumen fluid-buffer mixture, comprising McDougall buffer ([@b18-ajas-29-3-365]) and rumen fluid in the ratio of 4 to 1, was dispensed anaerobically into serum bottles containing 0.3 g of alfalfa substrate and additives 10% of substrate dry matter (DM), (free fatty acid form of CLA \[CLA-FFA\], nano-encapsulated CLA-FFA, triglyceride form of CLA \[CLA-TG\], nano-encapsulated CLA-TG). The serum bottles were filled with O~2~-free CO~2~ gas, and then capped with a rubber stopper. The bottles were kept in an incubator (JSGI-250T, JSR, Gongju, Korea) at 39°C for 6 h, 12 h, 24 h, and 48 h.

Measurement and analysis
------------------------

Incubation was terminated by taking the serum bottles from the incubator at the indicated times of 6 h, 12 h, 24 h, and 48 h. Total gas production from serum bottles at the end of each incubation period was measured through the three-way stopcock using a 50 mL glass syringe connected to a needle. The pH was measured by pH meter (MP-220K, Mettler-Toledo, Columbus, OH, USA). The supernatant and incubated mixture were transferred into a test tube and frozen at 20°C for further analysis of total volatile fatty acids (tVFAs), fatty acids and rumen microbial populations, respectively.

### Ethylation for fatty acid analysis

A total of 1 mL of medium to which 1 mg of heptadecanoic acid (C~17:0~) (H3500, Sigma, St. Louis, MO, USA) was added as an internal standard (IS) was extracted with 12 mL chloroform/methanol (1:1, v/v). The lower layer was mixed vigorously with 2 mL of 0.88% KCl solution and then evaporated with nitrogen until dry. The extracted lipids were ethylated using 10 mL of 2% H~2~SO~4~ in ethanol at 80°C for 60 min ([@b13-ajas-29-3-365]). After addition of 8 mL of saturated NaCl solution and 4 mL of n-hexane, fatty acid ethyl esters were obtained in the n-hexane layer; they were analyzed for total fatty acids, including CLA isomers, using a 7890A gas chromatograph with a flame ionization detector (Agilent Technologies, Wilmington, DE, USA). The fatty acid ethyl esters were separated using a Supelcowax-10-fused silica capillary column (100 m×0.25 mm inner diameter, 0.2 μm film thickness; Supelco, Inc., Bellefonte, PA, USA) with 1.2 mL/min of helium flow. The oven temperature was increased from 190°C to 240°C at the rate of 4°C/min. The temperature of both the injector and detector temperature was 260°C. In total, 1 μL of sample was injected into the column in the split mode (50:1). The peaks for each CLA isomer and other fatty acids were identified and quantified by comparing with the retention time and peak area of each fatty acid standard, respectively. IS was included as an internal reference before the extraction to determine the recovery of the fatty acids in each sample.

### Potential gas production curves

The gas production profiles in triplicate were fitted to the following equation using a non-linear procedure ([@b17-ajas-29-3-365]):

Y

=

A

(

1

\-

e

\-

c

(

t

\-

L

)

)

where *Y* is the volume of gas production (mL per 100 mg DM) at time *t*, *A* is gas production from soluble and insoluble fraction, *c* is the rate of gas production, *L* the lag time (h) and *t* is the incubation time (h).

### Volatile fatty acids (VFAs)

The sample was centrifuged at 13,500×g for 20 min, and the supernatant was used to determine the concentrations of VFA in the sample. The HPLC (L-2200, Hitachi, Tokyo, Japan) fitted with a UV detector (L-2400, Hitachi, Japan) and a silica gel column (Metacarb 87H, Varian, CA, USA) was used to measure VFA contents as described by [@b19-ajas-29-3-365].

### DNA extraction

A high-speed tissue homogenizer (Precellys 24, Bertin Crop., Rockville, MD, USA) which retains samples in screw-capped tubes containing silica beads was used for DNA extraction. Total nucleic acid was extracted from the incubated rumen samples by using the modified bead-beating protocol with the Soil kit (NucleoSpin Soil, Macherey-nagel Inc., Bethlehem, PA, USA). Nucleic acid concentrations were measured using a NanoDrop Spectrophotometer (ND-1000, Thermo Scientific, Wilmington, DE, USA).

### Polymerase chain reaction primers

The polymerase chain reaction (PCR) primer sets used for amplification of *Fibrobacter succinogenes* (*F. succinogenes*) (Forward-GGTATGGG ATGAGCTTGC, Reverse-GCCTGCCCCTGAACTATC) and *Butyrivibrio fibrisolvens* (Forward-TAACATGAGAGTTTGATCCTGGCTC, Reverse-CGTTACTCACCCGTCCGC) were the same as those referenced by [@b26-ajas-29-3-365] and [@b28-ajas-29-3-365], respectively. Total bacteria primer set (Forward-CGGCAACGAGCGCAACCC, Reverse-CCATTGTAGCACGTGTGTAGCC) was used as the internal standard ([@b4-ajas-29-3-365]).

### Real-time PCR

Real-time PCR (RT-PCR) assays for enumeration of microbes were performed according to the methods described by [@b4-ajas-29-3-365] and [@b5-ajas-29-3-365] on a real-time PCR Machine (7500 Real-Time PCR System, ABI, Foster City, CA, USA) using the SYBR Green kit (2×Mastermix w/Low-Rox kit, m.biotech, Hanam, Korea). The values of cycle threshold (Ct) after PCR reactions were used to determine the fold change (number of fold difference) of different microbial populations relative to control without additives. The abundance of these microbes was expressed by the equation: relative quantification = 2^−ΔCt(Target)\ −ΔCt(Control)^, where Ct represents the threshold cycle. All RT-PCR reaction mixtures (final volume, 20 μL) contained forward and reverse primers, the SYBR Green Supermix and DNA template (100 ng). A negative control without the template DNA was used in every RT-PCR assay for each primer. The RT-PCR amplification of the target DNA, including the annealing and the extension temperatures, was performed as previously described ([@b26-ajas-29-3-365]; [@b28-ajas-29-3-365]).

Statistical analysis
--------------------

All experiments were performed in triplicate, and data were expressed as means±standard deviations. Statistical analyses were performed by analysis of variation. The effects of nano-encapsulation on total gas production, pH and tVFA concentration were compared with the controls and significant differences between treatment means were examined using Duncan's multiple comparison tests. A p\<0.05 was considered to be statistically significant ([@b23-ajas-29-3-365]).

RESULTS AND DISCUSSION
======================

Biohydrogenation with nano-encapsulated CLA by *Butyrivibrio fibrisolvens*
--------------------------------------------------------------------------

The *cis*-9, *trans*-11 CLA isomer is an intermediate in the biohydrogenation of LA to stearic acid (SA) by the anaerobic rumen bacterium *B. fibrisolvens* ([@b11-ajas-29-3-365]). The conversion sequence of LA to SA involves at least three steps. The sequence begins with the isomerization of LA to *cis*-9, *trans*-11 CLA, followed by the hydrogenation of the *cis*-double bond of the conjugated diene to yield a *trans*-11 octadecenoic acid (*trans*-vaccenic acid). In addition, VA can also be converted to *cis*-9, *trans*-11 CLA by the Δ^9^-desaturase enzyme in mammary tissue, providing another mechanism for CLA formation in milk ([@b8-ajas-29-3-365]). This *in vitro* trial showed the protective effect of nano-encapsulated CLAs against the biohydrogenation activity of *B. fibrisolvens* ([Figure 1](#f1-ajas-29-3-365){ref-type="fig"}). The concentration of *cis*-9, *trans*-11 CLA was decreased, and that of VA was increased by CLA-FFA at the initial incubation time ([Figure 1a](#f1-ajas-29-3-365){ref-type="fig"}). Thereafter, no further decrease in the concentration of *cis*-9, *trans*-11 CLA was observed despite prolonged incubation. On the other hand, the concentration slightly was decreased by biohydrogenation when *B. fibrisolvens* was incubated with nano-encapsulated CLA-FFA ([Figure 1b](#f1-ajas-29-3-365){ref-type="fig"}). These findings showed that *B. fibrisolvens* had a high degree of biohydrogenation activity and low CLA-producing activity when incubated with CLA-FFA, and that CLA-FFA might be protected from the biohydrogenation acitivity of *B. fibrisolvens* by nano-encapsulation. In the group of *B. fibrisolvens* incubated with CLA-TG, *cis*-9, *trans*-11 CLA, and VA concentrations were decreased, while the concentrations further increased after incubation with nano-encapsulated ([Figure 1c, 1d](#f1-ajas-29-3-365){ref-type="fig"}). This finding showed that the nano-encapsulated CLA-TG was less protective against the biohydrogenation activity of *B.fibrisolvens* compared with CLA-TG. The CLA protection rates of CLA-FFA, nano-encapsulated CLA-FFA, CLA-TG, and nano-encapsulated CLA-TG after 48 h of incubation were 36%, 80%, 87%, and 73%, respectively. Therefore, nano-encapsulation was more effective against the *in vitro* biohydrogenation activity of *B. fibrisolvens* when incubated with CLA-FFA rather than CLA-TG. Nano-encapsulation, thus, might be used as an alternative technique to protect target materials against ruminal biohydrogenation in further studies.

*In vitro* ruminal fermentation characteristics with nano-encapsulated CLA
--------------------------------------------------------------------------

The *in vitro* ruminal fermentation profiles are shown in [Table 1](#t1-ajas-29-3-365){ref-type="table"}. The change in ruminal pH is an important factor not only for the amount of intermediates during biohydrogenation of LA but also for the microbial enzymatic activity in CLA production. [@b15-ajas-29-3-365] reported that the concentration of *trans*-11 C~18:1~ was increased more at pH 6.5 than at pH 5.5. In this *in vitro* ruminal fermentation, the pH was decreased by the addition of nano-encapsulated CLA-FFA and CLA-TG at 24 h incubation. The total gas production was significantly increased after 24 h incubation when nano-encapsulated CLA was added (p\<0.05). The potential *in vitro* ruminal fermentation and gas production curves are shown in [Table 2](#t2-ajas-29-3-365){ref-type="table"} and [Figure 2](#f2-ajas-29-3-365){ref-type="fig"}, respectively. Nano-encapsulated CLA-FFA and CLA-TG showed the higher potential for the ruminal fermentation than the control and non-nano-encapsulated CLA-FFA and CLA-TG. The tVFA concentration significantly was increased by nano-encapsulated CLA-FFA and CLA-TG compared with the control as well as CLA-FFA and CLA-TG after 24 h incubation. The effect of CLAs on the reduction rate of CLA in *in vitro* ruminal fermentation is shown in [Figure 3](#f3-ajas-29-3-365){ref-type="fig"}. The reduction rates of CLA concentration with CLAs (CLA-FFA, nano-encapsulated CLA-FFA, CLA-TG, and nano-encapsulated CLA-TG) were 23.9%, 30.9%, 31.1%, and 22.3% during the initial 12 h incubation, while they were 22.3%, 15.7%, 18.8%, and 27.0% during 12 to 24 h incubation, respectively. Although the rates of decrease in CLA concentration on incubation with CLA-FFA and nano-encapsulated CLA-TG were low at the initial incubation times, they were increased with the increase in incubation time. The total gas production and tVFAs concentration also were decreased by the addition of CLA-FFA and nano-encapsulated CLA-TG at the initial incubation times. The rate of decrease in CLA concentration when incubated with the nano-encapsulated CLA-FFA was the lowest from 12 to 24 h of incubation compared with the rates when other types of CLAs were added. These findings showed that nano-encapsulated CLA-FFA might in part influence the ruminal fermentation characteristics without adversely affecting incubation process, and might have a protective effect on ruminal biohydrogenation. The population change of *F. succinogenes* and *B. fibrisolvens* is shown in [Figure 4](#f4-ajas-29-3-365){ref-type="fig"}. The population of *F. succinogenes* was increased on incubation with nano-encapsulated CLA-FFA, while that of *B. fibrisolvens* was decreased in the *in vitro* ruminal fermentation ([Figure 4](#f4-ajas-29-3-365){ref-type="fig"}). According to the study of [@b9-ajas-29-3-365], bacteria play the important role in fatty acid biohydrogenation. *B. fibrisolvens* is the active bacteria isolated from the rumen as being most involved in biohydrogenation ([@b20-ajas-29-3-365]; [@b16-ajas-29-3-365]). The previous studies also reported that *B. fibrisolvens* was identified to form CLA and VA as intermediates during the biohydrogenation of LA ([@b22-ajas-29-3-365]; [@b11-ajas-29-3-365]). The nano-encapsulation might influence in the biohydrogenation pathways which is converted CLA to VA in this *in vitro* study, and thus the nano-encapsulated CLAs might lead to decrease in the *B. fibrisolvens* population.

In conclusion, protection from biohydrogenation and stability of CLA afforded by nano-encapsulation were examined under artificial rumen conditions to characterize the nano-encapsulated CLAs. We observed that the nano-encapsulated CLA-FFA was the most effective against the *in vitro* ruminal biohydrogenation without adversely affecting ruminal fermentation. Although these *in vitro* results do not completely explain the *in vivo* rumen ecosystem, nano-encapsulation could be applied to enhance CLA levels by increasing the stability of CLA in the ruminal ecosystem to enrich CLA in dairy products without adversely affecting ruminal fermentation. However this method should be further optimized by exploring other unknown environmental factors. An *in vivo* ruminal study is needed to better understand the biohydrogenation pathways of nano-encapsulated CLAs in ruminants.
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![The *in vitro* protection effects of conjugated linoleic acids (CLAs) against *B. fibrisolvens*. (a), free fatty acid form of CLA (CLA-FFA); (b) nano-encapsulated CLA-FFA; (c) triglyceride form of CLA (CLA-TG); (d) nano-encapsulated CLA-TG.](ajas-29-3-365f1){#f1-ajas-29-3-365}

![The potential gas production curves from the *in vitro* fermentation by addition of CLAs. F, free fatty acid form of CLA (CLA-FFA); NF, nano-encapsulated CLA-FFA; T, triglyceride form of CLA (CLA-TG); NT, nano-encapsulated CLA-TG.](ajas-29-3-365f2){#f2-ajas-29-3-365}

![The reduction rate of conjugated linoleic acids (CLA) concentration (%) in *in vitro* ruminal fermentation by the addition of CLAs. □, from 0 to 12 h of incubation; ■, from 12 to 24 h of incubation; F, free fatty acid form of CLA (CLA-FFA); NF, nano-encapsulated CLA-FFA; T, triglyceride form of CLA (CLA-TG); NT, nano-encapsulated CLA-TG.](ajas-29-3-365f3){#f3-ajas-29-3-365}

![Relative quantification analysis of microbes in *in vitro* ruminal fermentation by the addition of conjugated linoleic acids (CLAs) after 24 h incubation. F, free fatty acid form of CLA (CLA-FFA); NF, nano-encapsulated CLA-FFA; T, triglyceride form of CLA (CLA-TG); NT, nano-encapsulated CLA-TG.](ajas-29-3-365f4){#f4-ajas-29-3-365}

###### 

The effects of conjugated linoleic acids (CLAs) on ruminal fermentation characteristics for 48 h incubation

  Incubation time   Control                                               Treatments                                            SEM                                                                                                                                                               
  ----------------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- -------
                    ---------pH---------                                                                                                                                                                                                                                                          
  6 h               6.78[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}     6.71[ab](#tfn2-ajas-29-3-365){ref-type="table-fn"}    6.69[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}     6.72[ab](#tfn2-ajas-29-3-365){ref-type="table-fn"}    6.67[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}     0.026
  12 h              6.70[bc](#tfn2-ajas-29-3-365){ref-type="table-fn"}    6.76[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}     6.67[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}     6.72[ab](#tfn2-ajas-29-3-365){ref-type="table-fn"}    6.69[bc](#tfn2-ajas-29-3-365){ref-type="table-fn"}    0.016
  24 h              6.68[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}     6.60[ab](#tfn2-ajas-29-3-365){ref-type="table-fn"}    6.28[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}     6.55[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}     6.25[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}     0.026
  48 h              6.64[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}     6.51[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}     6.01[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}     6.51[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}     5.96[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}     0.025
                    ---------Gas production (mL/g DM)---------                                                                                                                                                                                                                                    
  6 h               36.67[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    28.87[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}    38.90[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    38.90[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    37.77[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    1.990
  12 h              74.43[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    44.43[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}    70.00[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    72.20[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    58.90[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}    2.488
  24 h              138.90[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}   98.87[d](#tfn2-ajas-29-3-365){ref-type="table-fn"}    172.23[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}   136.67[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}   159.43[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}   3.991
  48 h              162.23[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}   112.77[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}   225.00[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}   145.53[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}   213.33[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}   6.046
                    ---------tVFAs (mM)---------                                                                                                                                                                                                                                                  
  6 h               20.21[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    12.72[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}    14.45[bc](#tfn2-ajas-29-3-365){ref-type="table-fn"}   16.64[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}    11.93[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}    1.099
  12 h              25.54[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    20.37[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}    21.40[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}    24.86[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    21.06[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}    0.555
  24 h              35.20[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}    32.74[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}    45.88[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    35.07[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}    46.61[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    0.974
  48 h              40.93[c](#tfn2-ajas-29-3-365){ref-type="table-fn"}    37.48[d](#tfn2-ajas-29-3-365){ref-type="table-fn"}    61.76[b](#tfn2-ajas-29-3-365){ref-type="table-fn"}    38.05[cd](#tfn2-ajas-29-3-365){ref-type="table-fn"}   67.15[a](#tfn2-ajas-29-3-365){ref-type="table-fn"}    0.942

Control, none addition; F, free fatty acid form of CLA (CLA-FFA); NF, nano-encapsulated CLA-FFA; T, triglyceride form of CLA (CLA-TG); NT, nano-encapsulated CLA-TG; SEM, standard error of the mean; tVFAs, total volatile fatty acids.

Means in the same row with different superscripts differ significantly (p\<0.05).

###### 

The effects of conjugated linoleic acids (CLAs) on the potential gas production, specific rates of digestion and lag phase

  Item                                  Control                                               Treatments                                            SEM                                                   p-value                                                                                                               
  ------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------ ----------------------------------------------------- -------- ---------
  Gas production (mL per 100 mg DM)     177.67[b](#tfn4-ajas-29-3-365){ref-type="table-fn"}   124.03[c](#tfn4-ajas-29-3-365){ref-type="table-fn"}   271.03[a](#tfn4-ajas-29-3-365){ref-type="table-fn"}   154.23[bc](#tfn4-ajas-29-3-365){ref-type="table-fn"}   263.27[a](#tfn4-ajas-29-3-365){ref-type="table-fn"}   14.475   \<0.001
  Specific rates of digestion (per h)   0.070[ab](#tfn4-ajas-29-3-365){ref-type="table-fn"}   0.061[ac](#tfn4-ajas-29-3-365){ref-type="table-fn"}   0.039[c](#tfn4-ajas-29-3-365){ref-type="table-fn"}    0.083[a](#tfn4-ajas-29-3-365){ref-type="table-fn"}     0.045[bc](#tfn4-ajas-29-3-365){ref-type="table-fn"}   0.009    0.0319
  Lag phase (h)                         2.57                                                  2.28                                                  2.92                                                  2.80                                                   3.20                                                  0.573    NS
  R^2^                                  0.95                                                  0.86                                                  0.91                                                  0.89                                                   0.93                                                           

Control, none addition; F, free fatty acid form of CLA (CLA-FFA); NF, nano-encapsulated CLA-FFA; T, triglyceride form of CLA (CLA-TG); NT, nano-encapsulated CLA-TG; SEM, standard error of the mean; NS, not significantly.

Means in the same row with different superscripts differ significantly (p\<0.05).

[^1]: These authors contributed equally to this work.
